AMO launches its TFDA approved OCT, ApolloVue® S100 Image System, at the 8th Taiwan Dermatology Aesthetics Conference.
AMO’s cellular resolution FF-OCT system, ApolloVue® S100, made its first appearance at Taiwan Laser and Photonics Medicine Congress 2021.
AMO announced ApolloVue® S100 Image System has received Taiwan FDA approval.
AMO and NTU invited medical imaging experts — Dr. Milind Rajadhyaksha and Dr. Jason Chen from Memorial Sloan-Kettering Cancer Center came to Taiwan
Dr. Milind Rajadhyaksha is a mechanical and optical engineer and principal investigator in the Optical Imaging Laboratory in the Dermatology Service. His research focuses on creating novel confocal microscopes and endoscopes for imaging skin and head and neck cancers, and translating this technology to clinical applications in screening, diagnostics and surgical guidance. Chih-Shan Jason Chen […]
TAIPEI, Taiwan.—Apollo Medical Optics Inc. (Taipei, Taiwan) aims to revolutionize skin cancer detection without the need for invasive biopsies by using a single-crystal sapphire and yttrium aluminum garnet crystalline fibers—surrounded by glass and a flexible polymer cladding—to look through the skin and image suspicious skin anomalies non-invasively, instead of taking a skin sample and risk […]